Compile Data Set for Download or QSAR
maximum 50k data
Found 467 with Last Name = 'gravenfors' and Initial = 'y'
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50418800(CHEMBL1797395)
Affinity DataIC50:  9.33nMAssay Description:Inhibition of Nav1.7 by cell based whole-cell voltage clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50418784(CHEMBL1797399)
Affinity DataIC50:  10.5nMAssay Description:Inhibition of Nav1.7 by cell based whole-cell voltage clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398768(CHEMBL2180030)
Affinity DataIC50:  12nMAssay Description:Inhibition of human BACE1 using (europium)CEVNLDAEFK(Qsy7) as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by T...More data for this Ligand-Target Pair
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398774(CHEMBL2180031)
Affinity DataIC50:  14nMAssay Description:Inhibition of BACE1-mediated sAPPbeta release in human SH-SY5Y cells after 16 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181966(US9145380, 169)
Affinity DataIC50:  22nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50418789(CHEMBL1797391)
Affinity DataIC50:  22.9nMAssay Description:Inhibition of Nav1.7 by cell based whole-cell voltage clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50418791(CHEMBL1797388)
Affinity DataIC50:  24.0nMAssay Description:Inhibition of Nav1.7 by cell based whole-cell voltage clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398768(CHEMBL2180030)
Affinity DataIC50:  24nMAssay Description:Inhibition of BACE1-mediated sAPPbeta release in human SH-SY5Y cells after 16 hrs by ELISAMore data for this Ligand-Target Pair
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398774(CHEMBL2180031)
Affinity DataIC50:  26nMAssay Description:Inhibition of human BACE1 using (europium)CEVNLDAEFK(Qsy7) as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50418774(CHEMBL1797387)
Affinity DataIC50:  28.2nMAssay Description:Inhibition of Nav1.7 by cell based whole-cell voltage clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50418788(CHEMBL1797392)
Affinity DataIC50:  28.8nMAssay Description:Inhibition of Nav1.7 by cell based whole-cell voltage clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-secretase 2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398767(CHEMBL2180037)
Affinity DataIC50:  30nMAssay Description:Inhibition of human BACE2 using (europium)CEVNLDAEFK(Qsy7) as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM182037(US9145380, 240)
Affinity DataIC50:  31nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50491233(CHEMBL2380450)
Affinity DataIC50:  32nMAssay Description:Inhibition of BACE1-mediated soluble APPbeta release in human SH-SY5Y cells after 16 hrsMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398768(CHEMBL2180030)
Affinity DataIC50:  32nMAssay Description:Inhibition of human BACE1 using (europium)CEVNLDAEFK(Qsy7) as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by T...More data for this Ligand-Target Pair
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181846(US9145380, 49)
Affinity DataIC50:  36nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50418782(CHEMBL1797401)
Affinity DataIC50:  38.0nMAssay Description:Inhibition of Nav1.7 by cell based whole-cell voltage clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50491232(CHEMBL2380445)
Affinity DataIC50:  40nMAssay Description:Inhibition of BACE1-mediated soluble APPbeta release in human SH-SY5Y cells after 16 hrsMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181802(US9145380, 5)
Affinity DataIC50:  40nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM182009(US9145380, 212)
Affinity DataIC50:  41nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181815(US9145380, 18)
Affinity DataIC50:  44nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398768(CHEMBL2180030)
Affinity DataIC50:  49nMAssay Description:Inhibition of BACE1-mediated sAPPbeta release in human SH-SY5Y cells after 16 hrs by ELISAMore data for this Ligand-Target Pair
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM182005(US9145380, 208)
Affinity DataIC50:  55nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181833(US9145380, 36)
Affinity DataIC50:  57nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398769(CHEMBL2180014)
Affinity DataIC50:  58nMAssay Description:Inhibition of BACE1-mediated sAPPbeta release in human SH-SY5Y cells after 16 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50418775(CHEMBL1797413)
Affinity DataIC50:  58.9nMAssay Description:Inhibition of Nav1.7 by cell based whole-cell voltage clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398769(CHEMBL2180014)
Affinity DataIC50:  61nMAssay Description:Inhibition of human BACE1 using (europium)CEVNLDAEFK(Qsy7) as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50491225(CHEMBL2380446)
Affinity DataIC50:  63nMAssay Description:Inhibition of BACE1-mediated soluble APPbeta release in human SH-SY5Y cells after 16 hrsMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50418795(CHEMBL1797398)
Affinity DataIC50:  72.4nMAssay Description:Inhibition of Nav1.7 by cell based whole-cell voltage clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181803(US9145380, 6)
Affinity DataIC50:  74nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181903(US9145380, 106)
Affinity DataIC50:  74nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM182008(US9145380, 211)
Affinity DataIC50:  75nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181822(US9145380, 25)
Affinity DataIC50:  77nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398767(CHEMBL2180037)
Affinity DataIC50:  79nMAssay Description:Inhibition of human BACE1 using (europium)CEVNLDAEFK(Qsy7) as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by T...More data for this Ligand-Target Pair
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181801(US9145380, 4)
Affinity DataIC50:  79nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181980(US9145380, 183)
Affinity DataIC50:  81nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181849(US9145380, 52)
Affinity DataIC50:  84nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181889(US9145380, 92)
Affinity DataIC50:  91nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM182004(US9145380, 207)
Affinity DataIC50:  97nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398776(CHEMBL2180027)
Affinity DataIC50:  97nMAssay Description:Inhibition of human BACE1 using (europium)CEVNLDAEFK(Qsy7) as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50395945(CHEMBL2164565)
Affinity DataIC50:  100nMAssay Description:Antagonist activity at human TRPV1 expressed in CHO cells by IonWorks assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-secretase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398786(CHEMBL2180015)
Affinity DataIC50:  100nMAssay Description:Inhibition of BACE1-mediated sAPPbeta release in human SH-SY5Y cells after 16 hrs by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM182021(US9145380, 224)
Affinity DataIC50:  100nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM182014(US9145380, 217)
Affinity DataIC50:  110nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181840(US9145380, 43)
Affinity DataIC50:  110nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-secretase 2(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50398766(CHEMBL2180033)
Affinity DataIC50:  110nMAssay Description:Inhibition of human BACE2 using (europium)CEVNLDAEFK(Qsy7) as substrate incubated for 10 mins prior to substrate addition measured after 15 mins by T...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181831(US9145380, 34)
Affinity DataIC50:  120nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50418792(CHEMBL1797409)
Affinity DataIC50:  126nMAssay Description:Inhibition of Nav1.7 by cell based whole-cell voltage clamp electrophysiology assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM182013(US9145380, 216)
Affinity DataIC50:  130nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E synthase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM181798(US9145380, 1)
Affinity DataIC50:  130nMpH: 6.8Assay Description:A solution of test compound was added to a diluted microsome preparation containing human mPGES-1 and pre-incubated for 15 minutes in potassium phosp...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 467 total ) | Next | Last >>
Jump to: